Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0614 Injection, treosulfan, 50 milligrams

J Codes (Drugs)

Also known as: treosulfan, Ovastat, alkylating agent

Treosulfan injection, 50 milligrams, an alkylating agent used in myeloablative conditioning regimens for hematopoietic stem cell transplantation.

In Plain Language

bone marrow conditioning drug; transplant preparation chemotherapy

Clinical Context

Myeloablative agent for conditioning before hematopoietic stem cell transplant in patients with hematologic malignancies. May be preferred over busulfan in certain patient populations.

RVU Information

CPT J0614 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

hematology/oncologybone marrow transplanthospital medicine

Frequently Asked Questions

What is CPT code J0614?

CPT J0614 (Injection, treosulfan, 50 milligrams) is a J Codes (Drugs) code. Treosulfan injection, 50 milligrams, an alkylating agent used in myeloablative conditioning regimens for hematopoietic stem cell transplantation.

How is J0614 administered?

CPT J0614 is administered by a healthcare provider, typically via injection or infusion. Myeloablative agent for conditioning before hematopoietic stem cell transplant in patients with hematologic malignancies. May be preferred over busulfan in certain patient populations. It is used by hematology/oncology, bone marrow transplant, hospital medicine.

When is CPT J0614 used?

Myeloablative agent for conditioning before hematopoietic stem cell transplant in patients with hematologic malignancies. May be preferred over busulfan in certain patient populations.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.